Keith Woods - 07 Dec 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Keith Woods
Issuer symbol
RCKT
Transactions as of
07 Dec 2023
Net transactions value
$0
Form type
4
Filing time
12 Dec 2023, 20:51:09 UTC
Previous filing
08 Dec 2023
Next filing
11 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +20,522 $0.000000 20,522 07 Dec 2023 Common Stock 20,522 $26.30 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +11,960 $0.000000 11,960 07 Dec 2023 Common Stock 11,960 $26.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 20,522 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on December 7, 2026.
F2 This option represents a right to purchase a total of 11,960 shares of the Issuer's common stock, which will fully vest on December 7, 2024.